[CATECHOLAMINE EXCRETION AND THE CLINICAL PICTURE IN THE MANAGEMENT OF CARDIAC INFARCTION AND CORONARY INSUFFICIENCY WITH N 3-PHENYLPROPYL -(2) 1, 1-DIPHENYL-PROPYL-(3)-AMINE].
D001713:Biphenyl Compounds; D002395:Catecholamines; D003327:Coronary Disease; D004358:Drug Therapy; D004837:Epinephrine; D005853:Geriatrics; D007238:Infarction; D009203:Myocardial Infarction; D009573:Nitrites; D009638:Norepinephrine; D011299:Prenylamine; D014556:Urine
D001713:Biphenyl Compounds; D002395:Catecholamines; D004837:Epinephrine; D009573:Nitrites; D009638:Norepinephrine; D011299:Prenylamine; C010574:biphenyl
CORONARY DISEASE; DRUG THERAPY; EPINEPHRINE; GERIATRICS; MYOCARDIAL INFARCT; NITRITES; NOREPINEPHRINE; PRENYLAMINE; URINE
CATECHOLAMINAUSSCHEIDUNG UND KLINISCHES BILD BEI BEHANDLUNG VON HERZINFARKTEN UND KORONARINSUFFIZIENZEN MIT N 3-PHENYLPROPYL -(2) 1,1-DIPHENYL-PROPYL-(3)-AMIN.